Meningococcal Polysaccharide Vaccine Market, Global Outlook and Forecast 2022-2028

April 2022 | 77 pages | ID: MDF62B6DF358EN
Market Monitor Global

Abstracts

Meningococcal polysaccharide diphtheria conjugate vaccine is an active immunizing agent used to prevent infection by certain groups of meningococcal bacteria.

This report contains market size and forecasts of Meningococcal Polysaccharide Vaccine in global, including the following market information:

Global Meningococcal Polysaccharide Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Meningococcal Polysaccharide Vaccine Market Sales, 2017-2022, 2023-2028, (K Doses)

Global top five Meningococcal Polysaccharide Vaccine companies in 2021 (%)

The global Meningococcal Polysaccharide Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Polysaccharide Meningtitis AC Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Meningococcal Polysaccharide Vaccine include Sanofi, Bio-Med, CanSinoBIO, Walvax Biotechnology, Chongqing Zhifei Biological, Chengdu Kanghua Biological Products, Changsheng Biotechnology and CanSinoBIO, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Meningococcal Polysaccharide Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Meningococcal Polysaccharide Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Meningococcal Polysaccharide Vaccine Market Segment Percentages, by Type, 2021 (%)

• Polysaccharide Meningtitis AC
• Meningitis ACYW

Global Meningococcal Polysaccharide Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Meningococcal Polysaccharide Vaccine Market Segment Percentages, by Application, 2021 (%)

• 6 Months-15Year
• over 3 Year
• over 2 Year
• over 3 Months

Global Meningococcal Polysaccharide Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Meningococcal Polysaccharide Vaccine Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Meningococcal Polysaccharide Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Meningococcal Polysaccharide Vaccine revenues share in global market, 2021 (%)

Key companies Meningococcal Polysaccharide Vaccine sales in global market, 2017-2022 (Estimated), (K Doses)

Key companies Meningococcal Polysaccharide Vaccine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sanofi
• Bio-Med
• CanSinoBIO
• Walvax Biotechnology
• Chongqing Zhifei Biological
• Chengdu Kanghua Biological Products
• Changsheng Biotechnology
• CanSinoBIO

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Meningococcal Polysaccharide Vaccine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Meningococcal Polysaccharide Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MENINGOCOCCAL POLYSACCHARIDE VACCINE OVERALL MARKET SIZE

2.1 Global Meningococcal Polysaccharide Vaccine Market Size: 2021 VS 2028
2.2 Global Meningococcal Polysaccharide Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Meningococcal Polysaccharide Vaccine Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Meningococcal Polysaccharide Vaccine Players in Global Market
3.2 Top Global Meningococcal Polysaccharide Vaccine Companies Ranked by Revenue
3.3 Global Meningococcal Polysaccharide Vaccine Revenue by Companies
3.4 Global Meningococcal Polysaccharide Vaccine Sales by Companies
3.5 Global Meningococcal Polysaccharide Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Meningococcal Polysaccharide Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Meningococcal Polysaccharide Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Meningococcal Polysaccharide Vaccine Players in Global Market
  3.8.1 List of Global Tier 1 Meningococcal Polysaccharide Vaccine Companies
  3.8.2 List of Global Tier 2 and Tier 3 Meningococcal Polysaccharide Vaccine Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Meningococcal Polysaccharide Vaccine Market Size Markets, 2021 & 2028
  4.1.2 Polysaccharide Meningtitis AC
  4.1.3 Meningitis ACYW
4.2 By Type - Global Meningococcal Polysaccharide Vaccine Revenue & Forecasts
  4.2.1 By Type - Global Meningococcal Polysaccharide Vaccine Revenue, 2017-2022
  4.2.2 By Type - Global Meningococcal Polysaccharide Vaccine Revenue, 2023-2028
  4.2.3 By Type - Global Meningococcal Polysaccharide Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Meningococcal Polysaccharide Vaccine Sales & Forecasts
  4.3.1 By Type - Global Meningococcal Polysaccharide Vaccine Sales, 2017-2022
  4.3.2 By Type - Global Meningococcal Polysaccharide Vaccine Sales, 2023-2028
  4.3.3 By Type - Global Meningococcal Polysaccharide Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Meningococcal Polysaccharide Vaccine Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Meningococcal Polysaccharide Vaccine Market Size, 2021 & 2028
  5.1.2 6 Months-15Year
  5.1.3 over 3 Year
  5.1.4 over 2 Year
  5.1.5 over 3 Months
5.2 By Application - Global Meningococcal Polysaccharide Vaccine Revenue & Forecasts
  5.2.1 By Application - Global Meningococcal Polysaccharide Vaccine Revenue, 2017-2022
  5.2.2 By Application - Global Meningococcal Polysaccharide Vaccine Revenue, 2023-2028
  5.2.3 By Application - Global Meningococcal Polysaccharide Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Meningococcal Polysaccharide Vaccine Sales & Forecasts
  5.3.1 By Application - Global Meningococcal Polysaccharide Vaccine Sales, 2017-2022
  5.3.2 By Application - Global Meningococcal Polysaccharide Vaccine Sales, 2023-2028
  5.3.3 By Application - Global Meningococcal Polysaccharide Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Meningococcal Polysaccharide Vaccine Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Meningococcal Polysaccharide Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Meningococcal Polysaccharide Vaccine Revenue & Forecasts
  6.2.1 By Region - Global Meningococcal Polysaccharide Vaccine Revenue, 2017-2022
  6.2.2 By Region - Global Meningococcal Polysaccharide Vaccine Revenue, 2023-2028
  6.2.3 By Region - Global Meningococcal Polysaccharide Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Meningococcal Polysaccharide Vaccine Sales & Forecasts
  6.3.1 By Region - Global Meningococcal Polysaccharide Vaccine Sales, 2017-2022
  6.3.2 By Region - Global Meningococcal Polysaccharide Vaccine Sales, 2023-2028
  6.3.3 By Region - Global Meningococcal Polysaccharide Vaccine Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Meningococcal Polysaccharide Vaccine Revenue, 2017-2028
  6.4.2 By Country - North America Meningococcal Polysaccharide Vaccine Sales, 2017-2028
  6.4.3 US Meningococcal Polysaccharide Vaccine Market Size, 2017-2028
  6.4.4 Canada Meningococcal Polysaccharide Vaccine Market Size, 2017-2028
  6.4.5 Mexico Meningococcal Polysaccharide Vaccine Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Meningococcal Polysaccharide Vaccine Revenue, 2017-2028
  6.5.2 By Country - Europe Meningococcal Polysaccharide Vaccine Sales, 2017-2028
  6.5.3 Germany Meningococcal Polysaccharide Vaccine Market Size, 2017-2028
  6.5.4 France Meningococcal Polysaccharide Vaccine Market Size, 2017-2028
  6.5.5 U.K. Meningococcal Polysaccharide Vaccine Market Size, 2017-2028
  6.5.6 Italy Meningococcal Polysaccharide Vaccine Market Size, 2017-2028
  6.5.7 Russia Meningococcal Polysaccharide Vaccine Market Size, 2017-2028
  6.5.8 Nordic Countries Meningococcal Polysaccharide Vaccine Market Size, 2017-2028
  6.5.9 Benelux Meningococcal Polysaccharide Vaccine Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Meningococcal Polysaccharide Vaccine Revenue, 2017-2028
  6.6.2 By Region - Asia Meningococcal Polysaccharide Vaccine Sales, 2017-2028
  6.6.3 China Meningococcal Polysaccharide Vaccine Market Size, 2017-2028
  6.6.4 Japan Meningococcal Polysaccharide Vaccine Market Size, 2017-2028
  6.6.5 South Korea Meningococcal Polysaccharide Vaccine Market Size, 2017-2028
  6.6.6 Southeast Asia Meningococcal Polysaccharide Vaccine Market Size, 2017-2028
  6.6.7 India Meningococcal Polysaccharide Vaccine Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Meningococcal Polysaccharide Vaccine Revenue, 2017-2028
  6.7.2 By Country - South America Meningococcal Polysaccharide Vaccine Sales, 2017-2028
  6.7.3 Brazil Meningococcal Polysaccharide Vaccine Market Size, 2017-2028
  6.7.4 Argentina Meningococcal Polysaccharide Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Meningococcal Polysaccharide Vaccine Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Meningococcal Polysaccharide Vaccine Sales, 2017-2028
  6.8.3 Turkey Meningococcal Polysaccharide Vaccine Market Size, 2017-2028
  6.8.4 Israel Meningococcal Polysaccharide Vaccine Market Size, 2017-2028
  6.8.5 Saudi Arabia Meningococcal Polysaccharide Vaccine Market Size, 2017-2028
  6.8.6 UAE Meningococcal Polysaccharide Vaccine Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Sanofi
  7.1.1 Sanofi Corporate Summary
  7.1.2 Sanofi Business Overview
  7.1.3 Sanofi Meningococcal Polysaccharide Vaccine Major Product Offerings
  7.1.4 Sanofi Meningococcal Polysaccharide Vaccine Sales and Revenue in Global (2017-2022)
  7.1.5 Sanofi Key News
7.2 Bio-Med
  7.2.1 Bio-Med Corporate Summary
  7.2.2 Bio-Med Business Overview
  7.2.3 Bio-Med Meningococcal Polysaccharide Vaccine Major Product Offerings
  7.2.4 Bio-Med Meningococcal Polysaccharide Vaccine Sales and Revenue in Global (2017-2022)
  7.2.5 Bio-Med Key News
7.3 CanSinoBIO
  7.3.1 CanSinoBIO Corporate Summary
  7.3.2 CanSinoBIO Business Overview
  7.3.3 CanSinoBIO Meningococcal Polysaccharide Vaccine Major Product Offerings
  7.3.4 CanSinoBIO Meningococcal Polysaccharide Vaccine Sales and Revenue in Global (2017-2022)
  7.3.5 CanSinoBIO Key News
7.4 Walvax Biotechnology
  7.4.1 Walvax Biotechnology Corporate Summary
  7.4.2 Walvax Biotechnology Business Overview
  7.4.3 Walvax Biotechnology Meningococcal Polysaccharide Vaccine Major Product Offerings
  7.4.4 Walvax Biotechnology Meningococcal Polysaccharide Vaccine Sales and Revenue in Global (2017-2022)
  7.4.5 Walvax Biotechnology Key News
7.5 Chongqing Zhifei Biological
  7.5.1 Chongqing Zhifei Biological Corporate Summary
  7.5.2 Chongqing Zhifei Biological Business Overview
  7.5.3 Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Major Product Offerings
  7.5.4 Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Sales and Revenue in Global (2017-2022)
  7.5.5 Chongqing Zhifei Biological Key News
7.6 Chengdu Kanghua Biological Products
  7.6.1 Chengdu Kanghua Biological Products Corporate Summary
  7.6.2 Chengdu Kanghua Biological Products Business Overview
  7.6.3 Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Major Product Offerings
  7.6.4 Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Sales and Revenue in Global (2017-2022)
  7.6.5 Chengdu Kanghua Biological Products Key News
7.7 Changsheng Biotechnology
  7.7.1 Changsheng Biotechnology Corporate Summary
  7.7.2 Changsheng Biotechnology Business Overview
  7.7.3 Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Major Product Offerings
  7.7.4 Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Sales and Revenue in Global (2017-2022)
  7.7.5 Changsheng Biotechnology Key News
7.8 CanSinoBIO
  7.8.1 CanSinoBIO Corporate Summary
  7.8.2 CanSinoBIO Business Overview
  7.8.3 CanSinoBIO Meningococcal Polysaccharide Vaccine Major Product Offerings
  7.8.4 CanSinoBIO Meningococcal Polysaccharide Vaccine Sales and Revenue in Global (2017-2022)
  7.8.5 CanSinoBIO Key News

8 GLOBAL MENINGOCOCCAL POLYSACCHARIDE VACCINE PRODUCTION CAPACITY, ANALYSIS

8.1 Global Meningococcal Polysaccharide Vaccine Production Capacity, 2017-2028
8.2 Meningococcal Polysaccharide Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Meningococcal Polysaccharide Vaccine Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 MENINGOCOCCAL POLYSACCHARIDE VACCINE SUPPLY CHAIN ANALYSIS

10.1 Meningococcal Polysaccharide Vaccine Industry Value Chain
10.2 Meningococcal Polysaccharide Vaccine Upstream Market
10.3 Meningococcal Polysaccharide Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Meningococcal Polysaccharide Vaccine Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Meningococcal Polysaccharide Vaccine in Global Market
Table 2. Top Meningococcal Polysaccharide Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Meningococcal Polysaccharide Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Meningococcal Polysaccharide Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Meningococcal Polysaccharide Vaccine Sales by Companies, (K Doses), 2017-2022
Table 6. Global Meningococcal Polysaccharide Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Meningococcal Polysaccharide Vaccine Price (2017-2022) & (US$/Dose)
Table 8. Global Manufacturers Meningococcal Polysaccharide Vaccine Product Type
Table 9. List of Global Tier 1 Meningococcal Polysaccharide Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Meningococcal Polysaccharide Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Meningococcal Polysaccharide Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Meningococcal Polysaccharide Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Meningococcal Polysaccharide Vaccine Sales (K Doses), 2017-2022
Table 15. By Type - Global Meningococcal Polysaccharide Vaccine Sales (K Doses), 2023-2028
Table 16. By Application – Global Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Meningococcal Polysaccharide Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Meningococcal Polysaccharide Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Meningococcal Polysaccharide Vaccine Sales (K Doses), 2017-2022
Table 20. By Application - Global Meningococcal Polysaccharide Vaccine Sales (K Doses), 2023-2028
Table 21. By Region – Global Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Meningococcal Polysaccharide Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Meningococcal Polysaccharide Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Meningococcal Polysaccharide Vaccine Sales (K Doses), 2017-2022
Table 25. By Region - Global Meningococcal Polysaccharide Vaccine Sales (K Doses), 2023-2028
Table 26. By Country - North America Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Meningococcal Polysaccharide Vaccine Sales, (K Doses), 2017-2022
Table 29. By Country - North America Meningococcal Polysaccharide Vaccine Sales, (K Doses), 2023-2028
Table 30. By Country - Europe Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Meningococcal Polysaccharide Vaccine Sales, (K Doses), 2017-2022
Table 33. By Country - Europe Meningococcal Polysaccharide Vaccine Sales, (K Doses), 2023-2028
Table 34. By Region - Asia Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Meningococcal Polysaccharide Vaccine Sales, (K Doses), 2017-2022
Table 37. By Region - Asia Meningococcal Polysaccharide Vaccine Sales, (K Doses), 2023-2028
Table 38. By Country - South America Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Meningococcal Polysaccharide Vaccine Sales, (K Doses), 2017-2022
Table 41. By Country - South America Meningococcal Polysaccharide Vaccine Sales, (K Doses), 2023-2028
Table 42. By Country - Middle East & Africa Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Meningococcal Polysaccharide Vaccine Sales, (K Doses), 2017-2022
Table 45. By Country - Middle East & Africa Meningococcal Polysaccharide Vaccine Sales, (K Doses), 2023-2028
Table 46. Sanofi Corporate Summary
Table 47. Sanofi Meningococcal Polysaccharide Vaccine Product Offerings
Table 48. Sanofi Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 49. Bio-Med Corporate Summary
Table 50. Bio-Med Meningococcal Polysaccharide Vaccine Product Offerings
Table 51. Bio-Med Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 52. CanSinoBIO Corporate Summary
Table 53. CanSinoBIO Meningococcal Polysaccharide Vaccine Product Offerings
Table 54. CanSinoBIO Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 55. Walvax Biotechnology Corporate Summary
Table 56. Walvax Biotechnology Meningococcal Polysaccharide Vaccine Product Offerings
Table 57. Walvax Biotechnology Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 58. Chongqing Zhifei Biological Corporate Summary
Table 59. Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Product Offerings
Table 60. Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 61. Chengdu Kanghua Biological Products Corporate Summary
Table 62. Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Product Offerings
Table 63. Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 64. Changsheng Biotechnology Corporate Summary
Table 65. Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Product Offerings
Table 66. Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 67. CanSinoBIO Corporate Summary
Table 68. CanSinoBIO Meningococcal Polysaccharide Vaccine Product Offerings
Table 69. CanSinoBIO Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 70. Meningococcal Polysaccharide Vaccine Production Capacity (K Doses) of Key Manufacturers in Global Market, 2020-2022 (K Doses)
Table 71. Global Meningococcal Polysaccharide Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 72. Global Meningococcal Polysaccharide Vaccine Production by Region, 2017-2022 (K Doses)
Table 73. Global Meningococcal Polysaccharide Vaccine Production by Region, 2023-2028 (K Doses)
Table 74. Meningococcal Polysaccharide Vaccine Market Opportunities & Trends in Global Market
Table 75. Meningococcal Polysaccharide Vaccine Market Drivers in Global Market
Table 76. Meningococcal Polysaccharide Vaccine Market Restraints in Global Market
Table 77. Meningococcal Polysaccharide Vaccine Raw Materials
Table 78. Meningococcal Polysaccharide Vaccine Raw Materials Suppliers in Global Market
Table 79. Typical Meningococcal Polysaccharide Vaccine Downstream
Table 80. Meningococcal Polysaccharide Vaccine Downstream Clients in Global Market
Table 81. Meningococcal Polysaccharide Vaccine Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Meningococcal Polysaccharide Vaccine Segment by Type
Figure 2. Meningococcal Polysaccharide Vaccine Segment by Application
Figure 3. Global Meningococcal Polysaccharide Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Meningococcal Polysaccharide Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Meningococcal Polysaccharide Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Meningococcal Polysaccharide Vaccine Sales in Global Market: 2017-2028 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Meningococcal Polysaccharide Vaccine Revenue in 2021
Figure 9. By Type - Global Meningococcal Polysaccharide Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Meningococcal Polysaccharide Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Meningococcal Polysaccharide Vaccine Price (US$/Dose), 2017-2028
Figure 12. By Application - Global Meningococcal Polysaccharide Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Meningococcal Polysaccharide Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Meningococcal Polysaccharide Vaccine Price (US$/Dose), 2017-2028
Figure 15. By Region - Global Meningococcal Polysaccharide Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Meningococcal Polysaccharide Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Meningococcal Polysaccharide Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Meningococcal Polysaccharide Vaccine Sales Market Share, 2017-2028
Figure 19. US Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Meningococcal Polysaccharide Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Meningococcal Polysaccharide Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Meningococcal Polysaccharide Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Meningococcal Polysaccharide Vaccine Sales Market Share, 2017-2028
Figure 33. China Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Meningococcal Polysaccharide Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Meningococcal Polysaccharide Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Meningococcal Polysaccharide Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Meningococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Meningococcal Polysaccharide Vaccine Production Capacity (K Doses), 2017-2028
Figure 49. The Percentage of Production Meningococcal Polysaccharide Vaccine by Region, 2021 VS 2028
Figure 50. Meningococcal Polysaccharide Vaccine Industry Value Chain
Figure 51. Marketing Channels